SFRP5 and chronic kidney disease: Similarly, hypermethylation of the SFRP5 gene was observed in renal tubular cells and a mouse model of indoxyl sulfate‐driven chronic kidney disease, leading to reduced SFRP5 expression, Wnt/β‐catenin activation, and fibrosis progression [238].